Premium
HIV Cure: Knocking on the Door
Author(s) -
Durand C M,
Flexner C
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.22
Subject(s) - clinical pharmacology , human immunodeficiency virus (hiv) , medicine , bone marrow transplantation , intensive care medicine , leukemia , transplantation , pharmacology , immunology
Although major advances in drug development and public health are helping to control the HIV/AIDS epidemic, there is a strong rationale for pursuing a more definitive cure. Several bold but unproven strategies for HIV eradication are reviewed in this issue of CPT , including novel drugs, gene therapy, and bone marrow transplantation (BMT). Early results, including one probable case of HIV eradication in a leukemia patient, are intriguing but raise many questions. Clinical Pharmacology & Therapeutics (2013); 93 5, 382–384. doi: 10.1038/clpt.2013.22